Efficacy and Safety of TAK-875 in Combination With Sitagliptin in Participants With Type 2 Diabetes Mellitus
Public ClinicalTrials.gov record NCT01414920. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Placebo-Controlled, Factorial, Double-Blind, Double-Dummy, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of 25 mg and 50 mg of TAK-875 in Combination With Sitagliptin 100 mg in Subjects With Type 2 Diabetes Mellitus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the efficacy and safety of TAK-875, once daily (QD), in combination with sitagliptin QD in participants with type 2 diabetes mellitus (T2DM).
Study identification
- NCT ID
- NCT01414920
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 368 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2011 (Type not available)
- Primary completion
- Aug 2012 (Actual)
- Completion
- Aug 2012 (Actual)
- Last update posted
- Apr 4, 2016
2011 – 2012
United States locations
- U.S. sites
- 80
- U.S. states
- 26
- U.S. cities
- 80
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Brimingham | Alabama | — | — |
| Not listed | Chandler | Arizona | — | — |
| Not listed | Glendale | Arizona | — | — |
| Not listed | Green Valley | Arizona | — | — |
| Not listed | Mesa | Arizona | — | — |
| Not listed | Tempe | Arizona | — | — |
| Not listed | Tucson | Arizona | — | — |
| Not listed | Buena Park | California | — | — |
| Not listed | Irvine | California | — | — |
| Not listed | Norwalk | California | — | — |
| Not listed | Paramount | California | — | — |
| Not listed | Rancho Cucamonga | California | — | — |
| Not listed | San Ramon | California | — | — |
| Not listed | Spring Valley | California | — | — |
| Not listed | Vista | California | — | — |
| Not listed | Walnut Creek | California | — | — |
| Not listed | Westlake Village | California | — | — |
| Not listed | Colorado Springs | Colorado | — | — |
| Not listed | Lakewood | Colorado | — | — |
| Not listed | Brandon | Florida | — | — |
| Not listed | Clearwater | Florida | — | — |
| Not listed | DeLand | Florida | — | — |
| Not listed | Hallandale | Florida | — | — |
| Not listed | Hialeah | Florida | — | — |
| Not listed | Jupiter | Florida | — | — |
| Not listed | Longwood | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Miami Lakes | Florida | — | — |
| Not listed | Orlando | Florida | — | — |
| Not listed | Pembroke Pines | Florida | — | — |
| Not listed | St. Petersburg | Florida | — | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | Atlanta | Georgia | — | — |
| Not listed | Roswell | Georgia | — | — |
| Not listed | Suwanee | Georgia | — | — |
| Not listed | Boise | Idaho | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Valparaiso | Indiana | — | — |
| Not listed | Crestview Hills | Kentucky | — | — |
| Not listed | Lexington | Kentucky | — | — |
| Not listed | Louisville | Kentucky | — | — |
| Not listed | Bangor | Maine | — | — |
| Not listed | Elkridge | Maryland | — | — |
| Not listed | Brockton | Massachusetts | — | — |
| Not listed | Chelsea | Michigan | — | — |
| Not listed | Kalamazoo | Michigan | — | — |
| Not listed | Olive Branch | Mississippi | — | — |
| Not listed | Berlin | New Jersey | — | — |
| Not listed | Margate City | New Jersey | — | — |
| Not listed | Toms River | New Jersey | — | — |
| Not listed | Brooklyn | New York | — | — |
| Not listed | Buffalo | New York | — | — |
| Not listed | Calabash | North Carolina | — | — |
| Not listed | Fuquay-Varina | North Carolina | — | — |
| Not listed | Morehead City | North Carolina | — | — |
| Not listed | Winston-Salem | North Carolina | — | — |
| Not listed | Akron | Ohio | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Columbus | Ohio | — | — |
| Not listed | Lyndhurst | Ohio | — | — |
| Not listed | Marion | Ohio | — | — |
| Not listed | Willoughby Hills | Ohio | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Portland | Oregon | — | — |
| Not listed | Broomall | Pennsylvania | — | — |
| Not listed | Feasterville | Pennsylvania | — | — |
| Not listed | Fleetwood | Pennsylvania | — | — |
| Not listed | Cranston | Rhode Island | — | — |
| Not listed | Chattanooga | Tennessee | — | — |
| Not listed | Crossville | Tennessee | — | — |
| Not listed | Kingsport | Tennessee | — | — |
| Not listed | Nashville | Tennessee | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Irving | Texas | — | — |
| Not listed | North Richland Hills | Texas | — | — |
| Not listed | Pearland | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Seattle | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01414920, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 4, 2016 · Synced Nov 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01414920 live on ClinicalTrials.gov.